American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) 2024 Annual Meeting
Sep 28, 2024 at 9:30 AM - 10:30 AM EDT
Clint T. Allen, MD, National Cancer Institute (NCI) surgical oncology acting branch chief and lead investigator for the PRGN-2012 clinical trial, will discuss the preclinical development and Phase 1/2 clinical study results of PRGN-2012, a gorilla adenovirus gene therapy designed to enhance human papillomavirus (HPV)-specific immune responses in adult patients with recurrent respiratory papillomatosis.
Location
Miami Beach, FL